Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 8 (August)

1. Exaggerated neural response to emotional faces in patients with bipolar disorder and their first-degree relatives.
   Neuroimage, 53(1): 58-64. [Abstract] [Full-text]
2. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm.
   Psychiatry Res, 178(1): 84-91. [Abstract] [Full-text]
3. Mixture regression analysis on age at onset in bipolar disorder patients: investigation of the role of serotonergic genes.
   Eur Neuropsychopharmacol, 20(9): 663-70. [Abstract] [Full-text]
4. Mortality among psychiatric patients in Taiwan-Results from a universal National Health Insurance programme.
   Psychiatry Res, 178(1): 160-165. [Abstract] [Full-text]
5. Cross-informant agreement of the Dysregulation Profile of the Child Behavior Checklist.
   Psychiatry Res, 178(3): 550-5. [Abstract] [Full-text]
6. Neurocognitive correlates of emotional stimulus processing in pediatric bipolar disorder: a review.
   Postgrad Med, 122(4): 94-104. [Abstract] [Full-text]
7. Bipolar disorder: an update.
   Postgrad Med, 122(4): 24-31. [Abstract] [Full-text]
8. The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal.
   Postgrad Med, 122(4): 17-23. [Abstract] [Full-text]
9. Cognitive impairment in bipolar disorder: an overview.
   Postgrad Med, 122(4): 7-16. [Abstract] [Full-text]
10. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.
    Schizophr Res. [Abstract] [Full-text]
11. Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1).
    Psychiatry Res. [Abstract] [Full-text]
12. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder.
    Schizophr Res. [Abstract] [Full-text]
13. Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
14. Cannabis involvement in individuals with bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
15. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
16. The Hypomania Checklist-32 and the Mood Disorder Questionnaire as screening tools - going beyond samples of purely mood-disordered patients.
    J Affect Disord. [Abstract] [Full-text]
17. Subsyndromal depressive symptoms after symptomatic recovery from mania are associated with delayed functional recovery.
    J Clin Psychiatry. [Abstract] [Full-text]
18. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    J Clin Psychiatry. [Abstract] [Full-text]
19. McLean-Harvard international first-episode project: two-year stability of ICD-10s diagnoses in 500 first-episode psychotic disorder patients.
    J Clin Psychiatry. [Abstract] [Full-text]
20. Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
    Behav Brain Res, 214(2): 240-7. [Abstract] [Full-text]
21. Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
    Behav Brain Res, 214(2): 240-7. [Abstract] [Full-text]
22. Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
    Behav Brain Res, 214(2): 240-7. [Abstract] [Full-text]
23. Brainstorm: Occupational choice, bipolar illness and creativity.
    Econ Hum Biol, 8(2): 233-241. [Abstract] [Full-text]
24. Functional connectivity between ventral prefrontal cortex and amygdala at low frequency in the resting state in bipolar disorder.
    Psychiatry Res, 182(3): 207-10. [Abstract] [Full-text]
25. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.
    Am J Pathol, 177(2): 575-85. [Abstract] [Full-text]
26. Brain function in carriers of a genome-wide supported bipolar disorder variant.
    Arch Gen Psychiatry, 67(8): 803-11. [Abstract] [Full-text]
27. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
    Arch Gen Psychiatry, 67(8): 793-802. [Abstract] [Full-text]
28. Increased rates of events that activate or deactivate the behavioral approach system, but not events related to goal attainment, in bipolar spectrum disorders.
    J Abnorm Psychol, 119(3): 610-5. [Abstract] [Full-text]
29. Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice.
    Int Clin Psychopharmacol, 25(5): 257-63. [Abstract] [Full-text]
30. Age-related changes in the corpus callosum in early-onset bipolar disorder assessed using volumetric and cross-sectional measurements.
    Brain Imaging Behav. [Abstract] [Full-text]
31. Coexisting Psychiatric Problems and Stressful Life Events in Adults With Symptoms of ADHD--A Large Swedish Population-Based Study of Twins.
    J Atten Disord. [Abstract] [Full-text]
32. Cancer diagnosis in people with severe mental illness: practical and ethical issues.
    Lancet Oncol, 11(8): 797-804. [Abstract] [Full-text]
33. Assessment and treatment of bipolar II postpartum depression: a review.
    J Affect Disord, 125(1): 18-26. [Abstract] [Full-text]
34. Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: a prospective, 18-month follow-up study.
    J Affect Disord, 125(1): 74-81. [Abstract] [Full-text]
35. Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients?
    J Affect Disord, 125(1): 98-102. [Abstract] [Full-text]
36. Clinical and psychosocial correlates of non-suicidal self-injury within a sample of children and adolescents with bipolar disorder.
    J Affect Disord, 125(1): 89-97. [Abstract] [Full-text]
37. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
    J Affect Disord, 125(1): 165-8. [Abstract] [Full-text]
38. Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: a controlled study.
    J Affect Disord, 125(1): 27-34. [Abstract] [Full-text]
39. Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensions.
    J Affect Disord, 125(1): 82-8. [Abstract] [Full-text]
40. Risk factors for cognitive impairment in elderly bipolar patients.
    J Affect Disord, 125(1): 330-5. [Abstract] [Full-text]
41. Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.
    J Affect Disord, 125(1): 341-4. [Abstract] [Full-text]
42. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder.
    J Affect Disord, 125(1): 345-9. [Abstract] [Full-text]
43. Differences in neuroticism and extraversion between patients with bipolar I or II and general population subjects or major depressive disorder patients.
    J Affect Disord, 125(1): 42-52. [Abstract] [Full-text]
44. Bipolar disorder among adolescents and young adults: results from an epidemiological sample.
    J Affect Disord, 125(1): 350-4. [Abstract] [Full-text]
45. A population-based analysis of distinguishers of bipolar disorder from major depressive disorder.
    J Affect Disord, 125(1): 103-10. [Abstract] [Full-text]
46. Assessing disordered thoughts in preschoolers with dysregulated mood.
    Child Psychiatry Hum Dev, 41(5): 479-89. [Abstract] [Full-text]
47. Illness risk following rapid versus gradual discontinuation of antidepressants.
    Am J Psychiatry, 167(8): 934-41. [Abstract] [Full-text]
48. Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21?
    Am J Med Genet B Neuropsychiatr Genet, 153(6): 1200-8. [Abstract] [Full-text]
49. Role of oxidative stress in the pathophysiology of bipolar disorder.
    Neurochem Res, 35(9): 1295-301. [Abstract] [Full-text]
50. Suspected antidepressant-induced switch to mania in unipolar depression: a first-person narrative.
    J Affect Disord, 125(1): 111-5. [Abstract] [Full-text]
51. History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study.
    J Affect Disord, 125(1): 35-41. [Abstract] [Full-text]
52. Ecologically valid cognitive tests and everyday functioning in euthymic bipolar disorder patients.
    J Affect Disord, 125(1): 336-40. [Abstract] [Full-text]
53. Painting "Mania"
    J Affect Disord. [Abstract] [Full-text]
54. Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder.
    Psychiatry Res. [Abstract] [Full-text]
55. Prevalence of mixed mania using 3 definitions.
    J Affect Disord, 125(1): 61-73. [Abstract] [Full-text]
56. Mood reactivity to daily events in patients with remitted bipolar disorder.
    Psychiatry Res, 179(1): 47-52. [Abstract] [Full-text]
57. Three studies on self-report scales to detect bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
58. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort.
    J Psychiatr Res, 44(12): 748-53. [Abstract] [Full-text]
59. Is mood affected by interactions with people at risk for affective disorders?
    J Nerv Ment Dis, 198(8): 576-9. [Abstract] [Full-text]
60. Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation.
    J Psychopharmacol. [Abstract] [Full-text]
61. Cyclothymic and hyperthymic temperaments may predict bipolarity in major depressive disorder: A supportive evidence for bipolar II1/2 and IV.
    J Affect Disord. [Abstract] [Full-text]
62. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    World J Biol Psychiatry. [Abstract] [Full-text]
63. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Eur Neuropsychopharmacol. [Abstract] [Full-text]
64. Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
65. The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication.
    Mol Psychiatry, 15(8): 856-67. [Abstract] [Full-text]
66. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.
    Mol Psychiatry, 15(8): 844-9. [Abstract] [Full-text]
67. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene.
    Mol Psychiatry, 15(8): 810-5. [Abstract] [Full-text]
68. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study.
    Mol Psychiatry, 15(8): 831-43. [Abstract] [Full-text]
69. Defence and coping in bipolar affective disorder: stability and change of adaptational processes.
    Br J Clin Psychol, 49: 291-306. [Abstract] [Full-text]
70. The role of p38 MAPK in valproic acid induced microglia apoptosis.
    Neurosci Lett, 482(1): 51-6. [Abstract] [Full-text]
71. The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach.
    BMC Psychiatry, 10: 59. [Abstract] [Full-text]
72. Genome-wide searching of rare genetic variants in WTCCC data.
    Hum Genet, 128(3): 269-80. [Abstract] [Full-text]
73. Psychiatric correlates of bullying in the United States: findings from a national sample.
    Psychiatr Q, 81(3): 183-95. [Abstract] [Full-text]
74. Stability of Schizoaffective Disorder in Correlation with Duration of Follow-Up: Retrospective Analysis.
    Psychopathology, 43(5): 285-291. [Abstract] [Full-text]
75. Serum Brain-Derived Neurotrophic Factor in Euthymic Bipolar Patients on Prophylactic Lithium Therapy.
    Neuropsychobiology, 62(4): 229-234. [Abstract] [Full-text]
76. Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis.
    Acta Psychiatr Scand. [Abstract] [Full-text]
77. Bipolar affective disorder in the postnatal period: investigating the role of sleep.
    Bipolar Disord, 12(5): 568-78. [Abstract] [Full-text]
78. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence.
    Bipolar Disord, 12(5): 557-67. [Abstract] [Full-text]
79. Assessing oxidative pathway genes as risk factors for bipolar disorder.
    Bipolar Disord, 12(5): 550-6. [Abstract] [Full-text]
80. Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder.
    Bipolar Disord, 12(5): 541-9. [Abstract] [Full-text]
81. Performance of the Bipolar Spectrum Diagnostic Scale in psychiatric outpatients.
    Bipolar Disord, 12(5): 528-38. [Abstract] [Full-text]
82. The interactive computer interview for mania.
    Bipolar Disord, 12(5): 521-7. [Abstract] [Full-text]
83. Fibromyalgia and bipolar disorder: a potential problem?
    Bipolar Disord, 12(5): 514-20. [Abstract] [Full-text]
84. Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus.
    Bipolar Disord, 12(5): 504-13. [Abstract] [Full-text]
85. Clinical course of children with a depressive spectrum disorder and transient manic symptoms.
    Bipolar Disord, 12(5): 494-503. [Abstract] [Full-text]
86. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6 trial of the Danish University Antidepressant Group (DUAG-6).
    Bipolar Disord, 12(5): 483-93. [Abstract] [Full-text]
87. Functioning and disability in bipolar disorders: a systematic review of literature using the ICF as a reference.
    Bipolar Disord, 12(5): 473-82. [Abstract] [Full-text]
88. Circadian rhythms and sleep in bipolar disorder.
    Bipolar Disord, 12(5): 459-72. [Abstract] [Full-text]
89. Impaired verbal memory in young adults with unipolar and bipolar depression.
    Early Interv Psychiatry, 4(3): 227-33. [Abstract] [Full-text]
90. Functional analysis of upstream common polymorphisms of the dopamine transporter gene.
    Schizophr Bull, 36(5): 977-82. [Abstract] [Full-text]
91. Emerging drugs for bipolar disorder.
    Expert Opin Emerg Drugs, 15(3): 453-66. [Abstract] [Full-text]
92. Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders.
    Am J Addict, 19(5): 440-9. [Abstract] [Full-text]
93. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain.
    Epigenetics, 5(8). [Abstract] [Full-text]
94. Descriptive study of the occupational outcome of bipolar patients.
    J Occup Rehabil, 20(3): 293-8. [Abstract] [Full-text]
95. Association of seasonality and premenstrual symptoms in Bipolar I and Bipolar II disorders.
    J Affect Disord. [Abstract] [Full-text]
96. Glycogen synthesis in brain and astrocytes is inhibited by chronic lithium treatment.
    Neurosci Lett, 482(2): 128-32. [Abstract] [Full-text]
97. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: Results of the Korean epidemiologic catchment area study.
    Psychiatry Res. [Abstract] [Full-text]
98. Decreased self-reported arousal in schizophrenia during aversive picture viewing compared to bipolar disorder and healthy controls.
    Psychiatry Res. [Abstract] [Full-text]
99. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
    J Am Coll Cardiol, 56(9): 692-9. [Abstract] [Full-text]
100. Lithium modulates cortical excitability in vitro.
     Brain Res, 1352: 50-60. [Abstract] [Full-text]
101. Screening for bipolar disorders in Spanish-speaking populations: sensitivity and specificity of the Bipolar Spectrum Diagnostic Scale-Spanish Version.
     Compr Psychiatry, 51(5): 552-6. [Abstract] [Full-text]
102. A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder.
     Compr Psychiatry, 51(5): 504-9. [Abstract] [Full-text]
103. Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder.
     Compr Psychiatry, 51(5): 497-503. [Abstract] [Full-text]
104. Severity of affective temperament and maladaptive self-schemas differentiate borderline patients, bipolar patients, and controls.
     Compr Psychiatry, 51(5): 486-91. [Abstract] [Full-text]
105. Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour.
     World J Biol Psychiatry. [Abstract] [Full-text]
106. Atypical antipsychotic tolerability and switching strategies in bipolar disorder.
     Expert Opin Pharmacother. [Abstract] [Full-text]
107. White matter neuron alterations in schizophrenia and related disorders.
     Int J Dev Neurosci. [Abstract] [Full-text]
108. Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder.
     Psychoneuroendocrinology. [Abstract] [Full-text]
109. Case-control genome-wide association study of attention-deficit/hyperactivity disorder.
     J Am Acad Child Adolesc Psychiatry, 49(9): 906-20. [Abstract] [Full-text]
110. Predictors of relationship functioning for patients with bipolar disorder and their partners.
     J Fam Psychol, 24(4): 371-9. [Abstract] [Full-text]
111. Aggression in borderline personality disorder.
     Psychiatr Q, 81(3): 239-51. [Abstract] [Full-text]
112. Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women.
     BMC Gastroenterol, 10: 88. [Abstract] [Full-text]
113. Recognising prodromes of manic or depressive recurrence in outpatients with bipolar disorder: a cross-sectional study.
     Int J Nurs Stud, 47(10): 1201-7. [Abstract] [Full-text]
114. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
     J Clin Psychiatry, 71(8): 1000-6. [Abstract] [Full-text]
115. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder.
     J Clin Psychiatry, 71(8): 1055-60. [Abstract] [Full-text]
116. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior.
     Biol Psychiatry, 68(6): 503-11. [Abstract] [Full-text]
117. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.
     J Psychiatry Neurosci, 35(5): 296-302. [Abstract] [Full-text]
118. Osteoprotegerin levels in patients with severe mental disorders.
     J Psychiatry Neurosci, 35(5): 304-10. [Abstract] [Full-text]
119. Right orbitofrontal corticolimbic and left corticocortical white matter connectivity differentiate bipolar and unipolar depression.
     Biol Psychiatry, 68(6): 560-7. [Abstract] [Full-text]
120. Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals.
     Biol Psychiatry, 68(6): 586-8. [Abstract] [Full-text]
121. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
     J Clin Psychiatry, 71(8): e1-e21. [Abstract] [Full-text]
122. Increased sensitivity to light-induced melatonin suppression in premenstrual dysphoric disorder.
     Chronobiol Int, 27(7): 1438-53. [Abstract] [Full-text]
123. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review.
     J Affect Disord, 126(1): 1-13. [Abstract] [Full-text]
124. Patterns and predictors of restrictive health care service use by youths with bipolar disorder.
     Adm Policy Ment Health, 37(5): 379-87. [Abstract] [Full-text]
125. Postpartum bipolar episodes are not distinct from spontaneous episodes: Implications for DSM-V.
     J Affect Disord, 126(1): 61-4. [Abstract] [Full-text]
126. Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients.
     J Affect Disord, 126(1): 326-9. [Abstract] [Full-text]
127. Manic symptoms in patients with depressive and/or anxiety disorders.
     J Affect Disord, 126(1): 252-6. [Abstract] [Full-text]
128. Bipolar disorder with frequent mood episodes in the New Zealand Mental Health Survey.
     J Affect Disord, 126(1): 65-74. [Abstract] [Full-text]
129. Access to weight loss counseling services among patients with bipolar disorder.
     J Affect Disord, 126(1): 75-9. [Abstract] [Full-text]
130. Pre-morbid and outcome correlates of first episode mania with psychosis: Is a distinction between schizoaffective and bipolar I disorder valid in the early phase of psychotic disorders?
     J Affect Disord, 126(1): 88-95. [Abstract] [Full-text]
131. Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder.
     J Affect Disord, 126(1): 299-302. [Abstract] [Full-text]
132. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder.
     J Affect Disord, 126(1): 303-11. [Abstract] [Full-text]
133. Psychotic versus non-psychotic bipolar II disorder.
     J Affect Disord, 126(1): 55-60. [Abstract] [Full-text]
134. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample.
     J Affect Disord, 126(1): 312-6. [Abstract] [Full-text]
135. How effective is a psychological intervention program for patients with refractory bipolar disorder? A randomized controlled trial.
     J Affect Disord, 126(1): 80-7. [Abstract] [Full-text]
136. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
     Pharmacoeconomics, 28(9): 751-64. [Abstract] [Full-text]
137. Deficits in visual sustained attention differentiate genetic liability and disease expression for Schizophrenia from Bipolar Disorder.
     Schizophr Res. [Abstract] [Full-text]
138. Biological aspect of hyperthymic temperament: light, sleep, and serotonin.
     Psychopharmacology (Berl). [Abstract] [Full-text]
139. N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.
     J Affect Disord. [Abstract] [Full-text]
140. Effect of ionic stress on apoptosis and the expression of TRPM2 in human olfactory neuroepithelial-derived progenitors.
     World J Biol Psychiatry. [Abstract] [Full-text]
141. New-onset dissociative disorder after electroconvulsive therapy.
     J ECT, 26(3): 238-41. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.